- Generic name
- Halobetasol Propionate + Tazarotene
- Strength
- .01 gm + .045 gm/100 gm
- Dosage form
- Lotion
- Manufactured by
- The ACME Laboratories Ltd.
Halotaz Lotion
About Halotaz .01 gm + .045 gm/100 gm Lotion
Halotaz.01 gm +.045 gm/100 gm lotion is a medicine made by The ACME Laboratories Ltd. This Lotion is a combination of halobetasol propionate and tazarotene indicated for the topical treatment of plaque psoriasis in adults.
What is Halotaz .01 gm + .045 gm/100 gm Lotion?
The lotion Halotaz contains Halobetasol Propionate + Tazarotene and is made by The ACME Laboratories Ltd. A vasoconstrictor assay in healthy subje Tazarotene is a retinoid prodrug which is convert d to its active form, tazarotenic acid, the carboxylic acid of tazarotene, by deesterification. Whether it suits you is a decision for your doctor.
Uses of Halotaz
This Lotion is a combination of halobetasol propionate and tazarotene indicated for the topical treatment of plaque psoriasis in adults. Ask your doctor whether it is right for your condition.
How to use Halotaz
Do not attempt to inject it yourself. If you miss a dose, ask your doctor or pharmacist what to do. Complete the course exactly as prescribed.
Side effects of Halotaz
The most common side effects are redness, itching, swelling, burning, stinging, application site pain, inflamed hair follicles (folliculitis), thinning of the skin (atrophy), peeling and rash. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
Systemic absorption may require evaluation for HPA axis suppression. Use of potent corticosteroids on large a Reversible hypothalamic-pituitary-adrenal (HPA) axis suppression may occur, with the potential for glucocorticosteroid insufficiency during or after treatment. Keep out of reach of children.
Frequently asked questions
What does Halotaz treat?
This Lotion is a combination of halobetasol propionate and tazarotene indicated for the topical treatment of plaque psoriasis in adults. Ask your doctor whether it is right for your condition.
How is Halotaz used?
Do not attempt to inject it yourself. If you miss a dose, ask your doctor or pharmacist what to do.
What are the side effects of Halotaz?
The most common side effects are redness, itching, swelling, burning, stinging, application site pain, inflamed hair follicles (folliculitis), thinning of the skin (atrophy), peeling and rash. Tell your doctor if any side effect bothers you or does not go away.
Is Halotaz safe for everyone?
Systemic absorption may require evaluation for HPA axis suppression. Use of potent corticosteroids on large a Reversible hypothalamic-pituitary-adrenal (HPA) axis suppression may occur, with the potential for glucocorticosteroid insufficiency during or after treatment.
Indications
Pharmacology
A vasoconstrictor assay in healthy subjects with this lotion indicated that it is in the high to super-high range of potency as compared to other topical corticosteroids; however, similar blanching scores do not necessarily imply therapeutic equivalence. The potential for hypothalamic-pituitary-adrenal (HPA) axis suppression was evaluated in a study in adult subjects with moderate to severe plaque psoriasis. A median dose of 8.2 grams this lotion was applied once daily for 8 weeks and 20 subjects were assessed for HPA axis suppression at Weeks 4 and 8. HPA axis suppression was observed in 3 out of 20 (15%) subjects at Week 4. None of the 20 (0%) subjects had HPA axis suppression at Week 8. In this study, the criteria for HPA axis suppression was a serum cortisol level of less than or equal to 18 micrograms per deciliter 30 minutes after stimulation with cosyntropin (adrenocorticotropic hormone).
Dosage & Administration
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
- This lotion contains tazarotene, which is a teratogenic substance. In females of reproductive potential, obtain a negative pregnancy test within 2 weeks prior to initiating treatment and advise patients to use an effective method of contraception during treatment.
- Reversible hypothalamic-pituitary-adrenal (HPA) axis suppression may occur, with the potential for glucocorticosteroid insufficiency during or after treatment.
- Systemic effects of topical corticosteroids may also include Cushing’s syndrome, hyperglycemia, and glucosuria.
- Systemic absorption may require evaluation for HPA axis suppression.
- Use of potent corticosteroids on large areas, for prolonged durations, under occlusive dressings, or on an altered skin barrier may increase systemic exposure.
- Local Adverse Reactions: Local adverse reactions may include atrophy, striae, telangiectasias, and folliculitis. If these effects occur, discontinue at least until the integrity of the skin has been restored. DUOBRII Lotion should not be used on eczematous skin, as it may cause severe irritation.
- Photosensitivity and Risk for Sunburn: Avoid exposure to sunlight, sunlamps, and weather extremes. DUOBRII Lotion should be administered with caution if the patient is also taking drugs known to be photosensitizers.
- Ophthalmic Adverse Reactions: Use of topical corticosteroids may increase the risk of posterior subcapsular cataracts and glaucoma. If visual symptoms occur, consider referral to an ophthalmologist
Storage Conditions
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.